Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pan-European Trials in Adjuvant Colon Cancer (PETACC-2): Randomized Phase III Intergroup Trial of High-Dose Infusional 5-FU (+ or - Folinic Acid) Versus Standard Bolus 5-FU/Folinic Acid

NCT00004150 is registered in ClinicalTrials.gov with Robert Roessle Klinik as lead sponsor.

NCT NCT00004150
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00004150 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pan-European Trials in Adjuvant Colon Cancer (PETACC-2): Randomized Phase III Intergroup Trial of High-Dose Infusional 5-FU (+ or - Folinic Acid) Versus Standard Bolus 5-FU/Folinic Acid
Lead sponsor
Robert Roessle Klinik
Phase
Phase 3
Overall status
Completed
Start date
March 31, 1999
Completion date
April 30, 2007
Enrollment
Not reported
Sites
85

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer